Clinical and Experimental Pediatrics

The Korean Pediatric Society (대한소아청소년과학회)
권호 표지

Role of Mast Cells in Allergic Inflammation and Innate Immunity

비만세포의 알레르기 염증 반응과 Innate Immunity에서의 역할

An, Kang-Mo
안강모

  • Published : 20040000
⟨ Previous Next ⟩

Abstract

Mast cells play a key role in elicitation of the early-phase and late-phase IgE-mediated allergic inflammatory reactions. Mast cells are derived from pluripotent stem cells from the bone marrow. These cells migrate through circulation into connective tissues and mucosal surfaces where they mature. On the cell surfaces, mast cells have high affinity IgE receptor(FcεRI), which react with specific IgE to secrete preformed and newly synthesized mediators within minutes or over a period of hours. For human mast cells, two subtypes have been recognized by the distribution of granular neutral proteases. TC-type mast cells(MCTC) contain tryptase together with chymase, cathepsin-G, and carboxypeptidase, while T-type mast cells(MCT) contain tryptase only. They also produce Th2- type cytokines to persist chronic allergic inflammation in local tissues. Mast cells have been widely studied in the context of allergic reactions and parasite infections, but there is growing evidence that they participate in innate immunity, wound healing, fibrosis, remodelling and autoimmune disease. Much research works are expected to be underwent by the development of in vitro culture system of human mast cells in addition to mast cells obtained from animals, human biopsy or cell lines. In conclusion, it is clear that mast cells are pleiotropic, multipotential and complex. More detailed research remains to be needed for further understanding of biology of mast cells and it will be helpful to develop novel treatment modality in allergic inflammation.

Keywords

References

  1. Schwartz LB, Huff TF. Biology of mast cells. In:Middleton E, editor. Allergy:Principles and practice. 5th ed. Mosby:St. Louis, 1998:261-76
  2. Church MK, Bradding P, Walls AF, Okayama Y. Human mast cells and basophils. In Allergy and allergic diseases. 1st ed. MA:Blackwell Science, 1997:149-70
  3. Katz HR, Stevens RL, Austen KF. Heterogeneity of mammalian mast cells differentiates in vivo and in vitro. J Allergy Clin Immunol 1985;76:250-9
  4. Bienenstock J, Befus D, Denburg J, Goto T, Lee T, Otsuka H, Shanahan F. Comparative aspects of mast cell heterogeneity in different species and sites. Int Arch Allergy Appl Immunol 1985;77:126-9
  5. Nilsson G, Blom T, Kusche-Gullberg M, Kjellen L, Butterfield JH, Sundstrom C, et al. Phenotypic characterization of the human mast cell line HMC-1. Scand J Immunol 1994; 39:489-98
  6. Moller A, Henz BM, Grutzkau A, Lippert U, Aragane Y, Schwarz T, et al. Comparative cytokine gene expression:regulation and release by human mast cells. Immunology 1998;93:289-95
  7. Nilsson G, Svensson V, Nilsson K. Constitutive and inducible mRNA expression in the human mast cell line HMC-1. Scan J Immunol 1995;41:76-81
  8. Kirshenbaum AS, Goff JP, Kessler SW, Mican JM, Zsebo KM, Metcalfe DD. Effect of IL-3 and stem cell factor on the appearance of human basophils and mast cells from CD34＋ pluripotent progenitor cells. J Immunol 1992;148: 772-7
  9. Bressler RB, Lesko H, Jones ML, Wasserman M, Dickason RR, Huston MM, et al. Production of IL-5 and granulocyte-macrophage colony-stimulating factor by naive human mast cells activated by high-affinity IgE receptor ligation. J Allergy Clin Immunol 1997;99:508-14
  10. Valent P, Spanblochl E, Sperr WR, Sillaber C, Zsebo KM, Agis H, et al. Induction of differentiation of human mast cells from bone marrow and peripheral blood mononuclear cells by recombinant human stem cell factor/kit-ligand in long-term culture. Blood 1992;80:2237-45
  11. Rottem M, Okada T, Goff JP, Metcalfe DD. Mast cells cultured from the peripheral blood of normal donors and patients with mastocytosis originate from a CD34＋/FcεRI-cell population. Blood 1994;84:2489-96
  12. Mitsui H, Furitsu T, Dvorak AM, Irani AA, Schwartz LB, Inagaki N, et al. Development of human mast cells from umbilical cord blood cells by recombinant human and murine c-kit ligand. Proc Natl Acad Sci USA 1993;90:735-9
  13. Durand B, Migliaccio G, Yee NS, Eddleman K, Huima- Byron T, Migliaccio AR, et al. Long-term generation of human mast cells in the serum-free cultures of CD34＋ cord blood cells stimulated with stem cell factor and interleukin-3. Blood 1994;84:3667-74
  14. Saito H, Ebisawa M, Tachimoto H, Michitaka S, Fukagawa K, Matsumoto K, et al. Selective grwoth of human mast cells induced by steel factor, IL-6, and prostaglandin E2 from cord blood mononuclear cells. J Immunol 1996;157: 343-50
  15. Suzuki H, Takei M, Yanagida M, Nakahata T, Kawakami T, Fukamachi H. Early and late events in the FcεRI signal transduction in human cultured mast cells. J Immunol 1997;159:5881-8
  16. Irani AA, Nilsson G, Miettinen U, Craig SS, Ashman LK, Ishizaka T, et al. Recombinant human stem cell factor stimulates differentiation of mast cells from dispersed human fetal liver cells. Blood 1992;80:3009-21
  17. Xia HZ, Du Z, Craig S, Klisch G, Noben-Trauth N, Kochan JP, et al. Effect of recombinant human IL-4 on tryptase, chymase, and Fcε receptor type I expression in recombinant human stem cell factor-dependent fetal liver- derived human mast cells. J Immunol 1997;159:2911-21
  18. Kitamura Y, Go S, Hatanaka S. Decrease of mast cells in W/Wv mice and their increase by bone marrow transplantation. Blood 1978;52:447-52
  19. Kitamura Y, Go S. Decreased production of mast cells in Sl/Sld mice. Blood 1979;53:492-7
  20. Yanagida M, Fukamachi H, Ohgami K, Kuwaki T, Ishii H, Uzumaki H, et al. Effects of T-Helper 2-type cytokines, Interleukin-3(IL-3), IL-4, IL-5, and IL-6 on the survival of cultured human mast cells. Blood 1995;86:3705-14
  21. Nakahata T, Tsuji K, Tanaka R, Muraoka K, Okumura N, Sawai N, et al. Synergy of stem cell factor and other cytokines in mast cell development. In:Kitamura Y, Yamamoto S, Galli SJ, Greaves MW, editors. Biological and molecular aspects of mast cell and basophil differentiation and function. New York:Raven Press Co, 1995:13-24
  22. Ahn K, Takai S, Pawankar R, Kuramasu A, Ohtsu H, Kempuraj D, et al. Regulation of chymase production in human mast cell progenitors. J Allergy Clin Immunol 2000; 106:321-8
  23. Ahn KM, Lee KS, Shin MY, Park HY, Ahn YH, Son DY, et al. Effect of interleukin-9 on cell proliferation and histamine release of cord blood-derived human mast cells. Pediatr Allergy Respir Dis(Korea) 2002;12:282-90
  24. Temkin V, Kantor B, Weg V, Hartman ML, Levi-Schaffer F. Tryptase activates the mitogen-activated protein kinase/ actirvator protein-1 pathway in human peripheral blood eosionphils, causing cytokine production and release. J Immunol 2002;169:2662-9
  25. Toru H, Pawankar R, Ra C, Yata J, Nakahata T. Human mast cells produce IL-13 by high-affinity IgE receptor cross-linking:enhanced IL-13 production by IL-4-primed human mast cells. J Allergy Clin Immunol 1998;102:491- 502
  26. Brightling CE, Bradding P, Symon FA, Holgate ST, Wardlaw AJ, Pavord ID. Mast cell infiltration of airway smooth muscle in asthma N Engl J Med 2002;346:1699-705
  27. Levi-Schaffer F, Weg VB. Mast cells, eosinophils and fibrosis. Clin Exp Allergy 1997;27(suppl):64-70
  28. Humbert M, Grant JA, Taborda-Barata L, Durham SR, Pfister R, Menz G. High-affinity IgE receptor(Fcepsiolon RI)-bearing cells in bronchial biopsies from atopic and nonatopic asthma. Am J Respir Crit Care Med 1996;153: 1931-7
  29. Williams CM, Galli SJ. Mast cells can amplify airway reactivity and features of chronic inflammation in an asthma model in mice. J Exp Med 2000;192:455-62
  30. Malaviya R, Ikeda T, Ross E, Abraham SN. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-alpha. Nature 1996;381:77- 80
  31. Maurer M, Echtenacher B, Hultner L, Kollias G, Manuel DN, Langley KE, et al. The c-kit ligand, stem cell factor, can enhace innate immunity through effects on mast cells. J Exp Med 1998;188:2343-8
  32. McCurdy JD, Olynych TJ, Maher LH, Marshall JS. Distinct Toll-like receptor 2 activators selectively induce different classes of mediator production from human mast cells. J Immunol 2003;170:1625-9